Dennis Podlesak

Director

Dennis Podlesak (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Syndax Pharmaceuticals, Inc. (SNDX). The largest single filing was $875K of SNDX (57,600 sh across 3 lots, as filed), executed Aug 14 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$875K

shares × price, as filed

Last traded

Aug 18 2025

Filed Aug 18 2025

Median ADV $36.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $875K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 24 months

Most traded names

SNDX

Syndax Pharmaceuticals, Inc. SNDX · 0 buys · 1 sell 1 filing

Recent filings

SNDXSALE Syndax Pharmaceuticals, Inc. View filing → $875K
57,600 sh across 3 lots
Exec Aug 14 2025
Filed Aug 18 2025 · 5:30 PM ET